|
1
|
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman
M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C,
et al: Heart disease and stroke statistics-2017 update: A report
from the American heart association. Circulation. 135:e146–e603.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dubland JA and Francis GA: So much
cholesterol: The unrecognized importance of smooth muscle cells in
atherosclerotic foam cell formation. Curr Opin Lipidol. 27:155–161.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bennett MR, Sinha S and Owens GK: Vascular
smooth muscle cells in atherosclerosis. Circ Res. 118:692–702.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miano JM, Fisher EA and Majesky MW: Fate
and state of vascular smooth muscle cells in atherosclerosis.
Circulation. 143:2110–2116. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shankman LS, Gomez D, Cherepanova OA,
Salmon M, Alencar GF, Haskins RM, Swiatlowska P, Newman AC, Greene
ES, Straub AC, et al: KLF4-dependent phenotypic modulation of
smooth muscle cells has a key role in atherosclerotic plaque
pathogenesis. Nat Med. 21:628–637. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vengrenyuk Y, Nishi H, Long X, Ouimet M,
Savji N, Martinez FO, Cassella CP, Moore KJ, Ramsey SA, Miano JM
and Fisher EA: Cholesterol loading reprograms the
microRNA-143/145-myocardin axis to convert aortic smooth muscle
cells to a dysfunctional macrophage-like phenotype. Arterioscler
Thromb Vasc Biol. 35:535–546. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu Q, Zhang H, Lin J, Zhang R, Chen S,
Liu W, Sun M, Du W, Hou J and Yu B: C1q/TNF-related protein 9
inhibits the cholesterol-induced vascular smooth muscle cell
phenotype switch and cell dysfunction by activating AMP-dependent
kinase. J Cell Mol Med. 21:2823–2836. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Williams JW, Martel C, Potteaux S,
Esaulova E, Ingersoll MA, Elvington A, Saunders BT, Huang LH,
Habenicht AJ, Zinselmeyer BH and Randolph GJ: Limited macrophage
positional dynamics in progressing or regressing murine
atherosclerotic plaques-brief report. Arterioscler Thromb Vasc
Biol. 38:1702–1710. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Clemente C, Rius C, Alonso-Herranz L,
Martín-Alonso M, Pollán A, Camafeita E, Martínez F, Mota RA, Núñez
V, Rodríguez C, et al: MT4-MMP deficiency increases patrolling
monocyte recruitment to early lesions and accelerates
atherosclerosis. Nat Commun. 9:9102018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Förstermann U, Xia N and Li H: Roles of
vascular oxidative stress and nitric oxide in the pathogenesis of
atherosclerosis. Circ Res. 120:713–735. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Niemann B, Rohrbach S, Miller MR, Newby
DE, Fuster V and Kovacic JC: Oxidative stress and cardiovascular
risk: Obesity, diabetes, smoking, and pollution: Part 3 of a 3-part
series. J Am Coll Cardiol. 70:230–251. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li C, Zhang WJ and Frei B: Quercetin
inhibits LPS-induced adhesion molecule expression and oxidant
production in human aortic endothelial cells by p38-mediated Nrf2
activation and antioxidant enzyme induction. Redox Biol. 9:104–113.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Akoumianakis I and Antoniades C: Impaired
vascular redox signaling in the vascular complications of obesity
and diabetes mellitus. Antioxid Redox Signal. 30:333–353. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Frias JP, Bonora E, Nevárez Ruiz L, Hsia
SH, Jung H, Raha S, Cox DA, Bethel MA and Konig M: Efficacy and
safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than
65 and 65 years or older: Post hoc analysis of the AWARD-11 trial.
Diabetes Obes Metab. Jun 22–2021.(Epub ahead of print). View Article : Google Scholar
|
|
15
|
Chen X, Li X, Zhang W, He J, Xu B, Lei B,
Wang Z, Cates C, Rousselle T and Li J: Activation of AMPK inhibits
inflammatory response during hypoxia and reoxygenation through
modulating JNK-mediated NF-κB pathway. Metabolism. 83:256–270.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Q, Zhang M, Torres G, Wu S, Ouyang C,
Xie Z and Zou MH: Metformin suppresses diabetes-accelerated
atherosclerosis via the inhibition of Drp1-mediated mitochondrial
fission. Diabetes. 66:193–205. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bañuls C, Rovira-Llopis S, de Marañon AM,
Veses S, Jover A, Gomez M, Rocha M, Hernandez-Mijares A and Victor
VM: Metabolic syndrome enhances endoplasmic reticulum, oxidative
stress and leukocyte-endothelium interactions in PCOS. Metabolism.
71:153–162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan S, Zhang X, Zheng H, Hu D, Zhang Y,
Guan Q, Liu L, Ding Q and Li Y: Clematichinenoside inhibits VCAM-1
and ICAM-1 expression in TNF-α-treated endothelial cells via NADPH
oxidase-dependent IκB kinase/NF-κB pathway. Free Radic Biol Med.
78:190–201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Daiber A: Redox signaling (cross-talk)
from and to mitochondria involves mitochondrial pores and reactive
oxygen species. Biochim Biophys Acta. 1797:897–906. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou H, Zhang Y, Hu S, Shi C, Zhu P, Ma Q,
Jin Q, Cao F, Tian F and Chen Y: Melatonin protects cardiac
microvasculature against ischemia/reperfusion injury via
suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis.
J Pineal Res. 63:e124132017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He H, Guo F, Li Y, Saaoud F, Kimmis BD,
Sandhu J, Fan M, Maulik D, Lessner S, Papasian CJ, et al:
Adiporedoxin suppresses endothelial activation via inhibiting MAPK
and NF-κB signaling. Sci Rep. 6:389752016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Altieri P, Murialdo R, Barisione C,
Lazzarini E, Garibaldi S, Fabbi P, Ruggeri C, Borile S, Carbone F,
Armirotti A, et al: 5-fluorouracil causes endothelial cell
senescence: Potential protective role of glucagon-like peptide 1.
Br J Pharmacol. 174:3713–3726. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang M, Zeng S, Zou Y, Shi M, Qiu Q, Xiao
Y, Chen G, Yang X, Liang L and Xu H: The suppression of bromodomain
and extra-terminal domain inhibits vascular inflammation by
blocking NF-κB and MAPK activation. Br J Pharmacol. 174:101–115.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gerhardt T and Ley K: Monocyte trafficking
across the vessel wall. Cardiovasc Res. 107:321–330. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hsu WY, Chao YW, Tsai YL, Lien CC, Chang
CF, Deng MC, Ho LT, Kwok CF and Juan CC: Resistin induces
monocyte-endothelial cell adhesion by increasing ICAM-1 and VCAM-1
expression in endothelial cells via p38MAPK-dependent pathway. J
Cell Physiol. 226:2181–2188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moore KJ, Sheedy FJ and Fisher EA:
Macrophages in atherosclerosis: A dynamic balance. Nat Rev Immunol.
13:709–721. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun HJ, Zhao MX, Liu TY, Ren XS, Chen Q,
Li YH, Kang YM and Zhu GQ: Salusin-β induces foam cell formation
and monocyte adhesion in human vascular smooth muscle cells via
miR155/NOX2/NFκB pathway. Sci Rep. 6:235962016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hsu SY, Liou JW, Cheng TL, Peng SY, Lin
CC, Chu YY, Luo WC, Huang ZK and Jiang SJ: β-Naphthoflavone
protects from peritonitis by reducing TNF-α-induced endothelial
cell activation. Pharmacol Res. 102:192–199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lassegue B and Clempus RE: Vascular
NAD(P)H oxidases: Specific features, expression, and regulation. Am
J Physiol Regul Integr Comp Physiol. 285:R277–R297. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rasheduzzaman M, Yin H and Park SY:
Cardiac glycoside sensitized hepatocellular carcinoma cells to
TRAIL via ROS generation, p38MAPK, mitochondrial transition, and
autophagy mediation. Mol Carcinog. 58:2040–2051. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang P, Yin Y, Wang T, Li W, Li C, Zeng
X, Yang W, Zhang R, Tang Y, Shi L, et al: Maresin 1 mitigates
concanavalin A-induced acute liver injury in mice by inhibiting
ROS-mediated activation of NF-κB signaling. Free Radic Biol Med.
147:23–36. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Di Pino A and DeFronzo RA: Insulin
resistance and atherosclerosis: Implications for
insulin-sensitizing agents. Endocr Rev. 40:1447–1467. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang T and Redline S: Cross-sectional and
prospective associations of actigraphy-assessed sleep regularity
with metabolic abnormalities: The multi-ethnic study of
atherosclerosis. Diabetes Care. 42:1422–1429. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Roumie CL, Chipman J, Min JY, Hackstadt
AJ, Hung AM, Greevy RA Jr, Grijalva CG and Elasy T: Association of
treatment with metformin vs sulfonylurea with major adverse
cardiovascular events among patients with diabetes and reduced
kidney function. JAMA. 322:1167–1177. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Foretz M, Guigas B, Bertrand L, Pollak M
and Viollet B: Metformin: From mechanisms of action to therapies.
Cell Metab. 20:953–966. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fan Y, Yang Q, Yang Y, Gao Z, Ma Y, Zhang
L, Liang W and Ding G: Sirt6 suppresses high glucose-induced
mitochondrial dysfunction and apoptosis in podocytes through AMPK
activation. Int J Biol Sci. 15:701–713. 2019. View Article : Google Scholar : PubMed/NCBI
|
